Search results for "Blood Pressure"

showing 10 items of 1254 documents

Hemodynamic monitoring and management in patients undergoing high risk surgery: a survey among North American and European anesthesiologists

2011

Abstract Introduction Several studies have demonstrated that perioperative hemodynamic optimization has the ability to improve postoperative outcome in high-risk surgical patients. All of these studies aimed at optimizing cardiac output and/or oxygen delivery in the perioperative period. We conducted a survey with the American Society of Anesthesiologists (ASA) and the European Society of Anaesthesiology (ESA) to assess current hemodynamic management practices in patients undergoing high-risk surgery in Europe and in the United States. Methods A survey including 33 specific questions was emailed to 2,500 randomly selected active members of the ASA and to active ESA members. Results Overall,…

medicine.medical_specialtyCardiac outputbusiness.industrymedicine.medical_treatmentPulmonary artery catheterCentral venous pressureMEDLINEHemodynamicsPerioperativeCritical Care and Intensive Care MedicineBlood pressureAnesthesiologyEmergency medicineMedicinebusinessIntensive care medicineCritical Care
researchProduct

Alcohol puts the heart under pressure: Acetaldehyde activates a localized renin angiotensin aldosterone system within the myocardium in alcoholic car…

2018

medicine.medical_specialtyCardiomyopathyAlcoholBlood PressureAcetaldehyde030204 cardiovascular system & hematologyAlcoholic cardiomyopathyRenin-Angiotensin System03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineRenin–angiotensin systemReninmedicineHumans030212 general & internal medicineEthanolEthanolbusiness.industryAngiotensin IICardiomyopathy AlcoholicMyocardiumAcetaldehydemedicine.diseaseAngiotensin IIEndocrinologyBlood pressurechemistryCardiology and Cardiovascular MedicinebusinessInternational journal of cardiology
researchProduct

Special Considerations for Antihypertensive Agents in Dialysis Patients

2010

Hypertension is present in most patients with end-stage renal disease and likely contributes to the premature cardiovascular disease in dialysis patients. Previous practice guidelines have recommended that, in patients on chronic dialysis, blood pressure (BP) should be reduced below 130/80 mm Hg. This is based on opinions but not strong evidence, since no concrete information exists about which BP values should be the parameter to follow and which should be the target BP values. The majority of the antihypertensive agents can be used in this population, but the pharmacokinetics altered by the impaired kidney function and dialyzability influence the appropriate dosage as well as the time and…

medicine.medical_specialtyCardiotonic AgentsHypertension RenalCombination therapyMetabolic Clearance Ratemedicine.drug_classVasodilator Agentsmedicine.medical_treatmentAdrenergic beta-AntagonistsPopulationAngiotensin-Converting Enzyme InhibitorsCardiotonic AgentsRenal DialysisInternal medicinemedicineHumansDrug InteractionsDiureticseducationAntihypertensive drugAntihypertensive AgentsDialysisRandomized Controlled Trials as Topiceducation.field_of_studybusiness.industryHematologyGeneral MedicineCalcium Channel Blockersmedicine.diseaseEndocrinologyBlood pressureCardiovascular DiseasesNephrologyPractice Guidelines as TopicPolypharmacyKidney Failure ChronicDrug Therapy CombinationHemodialysisbusinessAngiotensin II Type 1 Receptor BlockersKidney diseaseBlood Purification
researchProduct

Oral administration of the growth hormone secretagogue NN703 in adult patients with growth hormone deficiency

2003

Summary objective Little is known of the usefulness of GH secretagogues (GHSs) in GH-deficient (GHD) adults. The objective of this study was to determine the number of responders to treatment with NN703 in GHD adults. design A multicentre, randomized, double-blind, and placebo-controlled study. patients Ninety-seven GHD adults were included. measurements The GH response before and after 1 week of oral treatment with NN703 (n = 83) or placebo (n = 14) was determined. The first and last dose of NN703 was 3 mg/kg, whereas the dose of NN703 was 1·5 mg/kg/day during the 6 days between the first and last doses. Furthermore, all 97 patients received 1 µg/kg GH-releasing hormone (GHRH) 3 weeks afte…

medicine.medical_specialtyChemotherapybusiness.industryEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPlacebomedicine.diseaseGrowth hormone deficiencyEndocrinologyBlood pressureEndocrinologyOral administrationGrowth hormone secretagogueInternal medicineStatistical significancemedicinebusinessHormoneClinical Endocrinology
researchProduct

Clinical and research aspects of ambulatory blood pressure monitoring in children.

2004

medicine.medical_specialtyClinical Trials as TopicAmbulatory blood pressurebusiness.industryHemodynamicsBlood Pressure Monitoring AmbulatorySurgeryMean blood pressureBlood pressureTreatment OutcomeReference ValuesInternal medicinePediatrics Perinatology and Child HealthHypertensionmedicineCardiologyHumansbusinessChildBody mass indexThe Journal of pediatrics
researchProduct

24-hour Ambulatory BP Monitoring and Home BP Measurements in Resistant Hypertension

2013

Out-of-office BP measurements, ambulatory BP monitoring (ABPM), and self-BP measurement play an important role in the evaluation of resistant hypertension. In fact 24 h ABPM has been considered mandatory at the time to evaluate resistant hypertension from the beginning of clinical use. Furthermore, clinical research has expanded the potential role of out-of-office measurements not only to the initial evaluation of resistant hypertension but also to refine cardiovascular and renal risk stratification and for a better follow-up. The widespread use of self-BP measurement at home introduced a new tool to properly assess out-of-office BP, and it has also been recommended in these patients althou…

medicine.medical_specialtyClinical researchAmbulatory blood pressurebusiness.industryEmergency medicineRisk stratificationResistant hypertensionMedicinebusiness
researchProduct

Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Socie…

2020

This is a pre-copyedited, author-produced version of an article accepted for publication in European Journal of Preventive Cardiology following peer review. The version of record Piepoli, M.F., Abreu, A., Albus, C., Ambrosetti, M., Brotons, C., Catapano, A.L. ... Tiberi, M. (2020). Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology*. European Journal of Preventive Cardiology (EJPC), 27(2), 181-205 is available online at: https://doi.org/10.1177/2047487319893035. European guidelines on cardiovascular prevention in clinical practice were first published in 1994 and have been regu…

medicine.medical_specialtyConsensusEpidemiologyCost effectivenessCost-Benefit AnalysisPopulationCardiologyPsychological interventionphysical activitypopulationGuidelinesrisk managementsmokingrehabilitationlipidsprimary carepreventionhealthy lifestyleInternal medicinePreventive Health ServicesEpidemiologyHumansMedicineguidelineseducationpsychosocial factorsstakeholderRisk managementeducation.field_of_studyVDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin sosialmedisin: 801diabetesbusiness.industryStakeholderblood pressurerisk assessmentHealth Care CostsProtective FactorsPrognosisnutritionCardiovascular DiseasesHeart Disease Risk FactorsCardiologyPosition paperCardiology and Cardiovascular MedicinebusinessRisk assessmentclinical settings
researchProduct

Hypertension is strongly associated with false-positive bicycle exercise stress echocardiography testing results

2016

Exercise echocardiography is a reliable routine test in patients with known or suspected coronary artery disease. However, in ∼15% of all patients, stress echocardiography leads to false-positive stress echocardiography results. We aimed to investigate the impact of hypertension on stress echocardiographic results.We performed a retrospective study of patients with suspected or known stable coronary artery disease who underwent a bicycle exercise stress echocardiography. Patients with false-positive stress results were compared with those with appropriate results.126 patients with suspected or known coronary artery disease were included in this retrospective study. 23 patients showed false-…

medicine.medical_specialtyCoronary Disease030204 cardiovascular system & hematologyCoronary artery disease03 medical and health sciences0302 clinical medicineInternal medicineInternal MedicinemedicineStress EchocardiographyHumansIn patient030212 general & internal medicineRetrospective Studiesbusiness.industryGender distributionRetrospective cohort studyGeneral Medicinemedicine.diseaseBicyclingBlood pressuremedicine.anatomical_structureEchocardiographyHypertensionExercise TestCardiologyExercise stress echocardiographyCardiology and Cardiovascular MedicinebusinessEchocardiography StressArteryBlood Pressure
researchProduct

Effects of the Combination of Candesartan plus Captopril in Elderly Patients with Anterior Myocardial Infarction

2000

Objective: To verify the feasibility, tolerability and efficacy of the combination of captopril (75 mg/day) and candesartan (8 mg/day) in early postinfarction phases of not thrombolysed and unreperfused anterior acute myocardial infarction (AMI) in elderly patients. Design and Patients: 71 patients (aged >65 years) hospitalised for anterior AMI were randomised in a double-blind manner into two groups: group A included 35 patients who received captopril 75 mg/day within 3 days of admission plus candesartan 4mg, as a first dose, and 8 mg/day successively; group B included 36 patients who received captopril 75 mg/day and placebo. 90 days after admission, patients underwent echocardiography to …

medicine.medical_specialtyCreatinineEjection fractionbusiness.industryCaptoprilGeneral MedicinePlacebomedicine.diseaseCandesartanchemistry.chemical_compoundBlood pressurechemistryTolerabilityInternal medicineCardiologyMedicinePharmacology (medical)Myocardial infarctionbusinessmedicine.drugClinical Drug Investigation
researchProduct

Abnormal Haemostasis and Blood Viscosity in Malignant Hypertension

1984

SummaryWe have previously shown abnormalities of haemostasis suggestive of intravascular coagulation in patients with malignant hypertension, a condition associated with retinopathy and renal fibrin deposition. To determine whether such abnormalities are specific to malignant hypertension, we have measured several haemostatic and haemorheological variables in 18 patients with malignant hypertension (Group 1), 18 matched healthy controls (Group 2), and 18 patients with non-malignant hypertension (Group 3) matched for renal pathology, blood pressure and serum creatinine with Group 1. Both Groups 1 and 3 had increased mean levels of fibrinogen, factor VIIIc, beta-thrombo- globulin, plasma visc…

medicine.medical_specialtyCreatininebiologybusiness.industryAntithrombinBlood viscosityHematologyFibrinogenGastroenterologyFibrinchemistry.chemical_compoundBlood pressurechemistryRenal pathologyInternal medicineHemostasismedicinebiology.proteinbusinessmedicine.drugThrombosis and Haemostasis
researchProduct